#Neglected Tropical Disease Diagnosis Market

[waquasuniverse]

Neglected Tropical Diseases Diagnosis Market To Reach $8.97Bn By 2030

The global neglected tropical diseases diagnosis market size is expected to reach USD 8.97 billion by 2030, expanding at a CAGR of 4.5% during the forecast period, according to a new report by Grand View Research, Inc. Increasing disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand. Increasing concern…

[vanshika393]

Hydatid Disease Treatment Market - Rising Trends and Research Outlook 2024-2030 | Credence Research

The latest market report published by Credence Research, Inc. “Global Hydatid Disease Treatment Market: Growth, Future Prospects, and Competitive Analysis, 2023 – 2030. The global hydatid disease treatment market has witnessed rapid growth in recent years and is expected to grow at a CAGR of 5.6% between 2023 and 2030. The market was valued at USD XX million in 2022 and is expected to reach USD XX million in 2030.

The Hydatid Disease Treatment Market refers to the global healthcare industry segment dedicated to the development, production, and distribution of medical products and services for the treatment of hydatid disease, also known as echinococcosis. This parasitic infection is caused by the tapeworm Echinococcus, primarily Echinococcus granulosus and Echinococcus multilocularis, and it can affect various organs in the human body, most commonly the liver and lungs.

The market for hydatid disease treatment encompasses a range of pharmaceuticals, medical devices, diagnostic tools, and surgical interventions aimed at diagnosing, managing, and curing this disease. Treatment options may include antiparasitic medications, surgical removal of cysts, and supportive therapies to address complications and associated health issues.

Hydatid Disease Treatment Market Dynamics

The hydatid disease treatment market is witnessing dynamic growth and evolving at a compelling pace. Hydatid disease, also known as echinococcosis, is a parasitic infection caused by the tapeworm Echinococcus. This formidable global health challenge has necessitated significant advancements in its treatment options, driving the progress of the hydatid disease treatment market. The rise in global awareness about this neglected tropical disease has spurred research and development activities to develop novel therapeutic interventions.

Various factors contribute to the momentum observed within this market, such as increasing government initiatives towards eradicating hydatid diseases, growing healthcare expenditure globally, and rising prevalence rates in several regions across the world. As medical expertise expands alongside technological advancements, multiple diagnostic methods are being developed for early detection of these infections which further fuel demand for effective treatments.

Additionally, collaborations between pharmaceutical companies and research institutes have materialized into robust pipelines for innovative drug candidates that promise improved efficacy with reduced side effects. With all these elements converging harmoniously within this dynamic marketplace, it holds immense potential for advancement while offering hope to patients grappling with this debilitating condition.

Some of the major players in the market and their market share are as follows:

Amneal Pharmaceuticals LLC

GSK Plc

Abbott Laboratories Inc

Merck KGaA

Janssen Global Services LLC (Johnson & Johnson Services Inc)

Lupin Limited

Cadila Pharmaceuticals Limited

Zydus Group

Mankind Pharma

Hydatid Disease Treatment Market Major Challenges and Risks

The Hydatid Disease Treatment Market poses several major challenges and risks to stakeholders involved. One of the primary hurdles is the limited availability and accessibility of effective treatment options. Currently, there are only a few drugs approved for hydatid disease treatment, and these medications often come with various side effects that may limit their use in certain patients.

Additionally, due to the rarity of this disease in developed countries, research funding and resources remain scarce, making it difficult to develop innovative therapies or conduct extensive clinical trials. Another significant challenge lies in the accurate diagnosis of this condition, as it requires advanced imaging techniques and expertise. Misdiagnosis can lead to delayed treatments or inappropriate prescriptions that may worsen the patient's condition. Furthermore, inadequate awareness among healthcare professionals about hydatid disease can result in underestimation or mismanagement of cases leading to suboptimal outcomes for patients.

Browse 246 pages report Hydatid Disease Treatment Market By Treatment Type (Medical Treatment, Antiparasitic Medications (e.g., Albendazole, Mebendazole), Surgical Treatment, Cyst Removal (Cystectomy), Cyst Aspiration and Injection of Protoscolicidal Agent (PAIR), Partial Liver Resection, Other Surgical Procedures), By Site of Infection (Hepatic Hydatid Disease (Infection in the Liver), Pulmonary Hydatid Disease (Infection in the Lungs), Other Organs (e.g., Brain, Kidneys) – Growth, Share, Opportunities & Competitive Analysis, 2023 – 2030 - https://www.credenceresearch.com/report/hydatid-disease-treatment-market

Hydatid Disease Treatment Market Partners and Acquisitions

Hydatid Disease Treatment Market partners and acquisitions play a pivotal role in shaping the landscape of this specialized healthcare sector. As researchers and pharmaceutical companies strive to develop innovative treatments, strategic collaborations become essential for maximizing expertise and resources. These partnerships often facilitate advancements in diagnostic techniques, therapeutic options, and overall patient care. Established players within the Hydatid Disease Treatment Market seek to expand their reach through targeted acquisitions, enabling them to tap into novel markets or enhance their existing product portfolios.

By joining forces with other industry leaders or emerging startups, companies gain access to cutting-edge technologies that can revolutionize the way hydatid disease is diagnosed and treated. The synergy created by these partnerships fosters collaboration between different stakeholders such as clinicians, researchers, regulatory bodies, and investors – all working towards a common goal of better outcomes for patients afflicted by this debilitating condition.

This ecosystem encourages continuous innovation while also providing a platform for sharing knowledge and best practices among market participants. Overall, the seamless integration of diverse expertise through partner collaborations ensures that the Hydatid Disease Treatment Market remains dynamic and responsive to evolving healthcare needs worldwide.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Hydatid Disease Treatment Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Hydatid Disease Treatment Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Complete Report- https://www.credenceresearch.com/report/hydatid-disease-treatment-market

Visit our Website- https://www.credenceresearch.com/

Related Reports- https://www.credenceresearch.com/report/comt-inhibitors-market

Browse Our Blog- https://www.linkedin.com/pulse/hydatid-disease-treatment-market-size-trends-analysis-shukla

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[market-insider]

Neglected Tropical Disease Diagnosis Market Worth $7.6 Billion By 2025

The global neglected tropical diseases diagnosis market size is expected to reach USD 7.6 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 4.1% CAGR during the forecast period. The combined effect of high impact factors such as soaring disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Rising concern regarding Neglected Tropical Diseases (NTD) and its global impact on population as well as governments has fueled demand for development of early disease detection methods. This growth in concern is evident by launch of a substantial number of programs aiming to combat NTDs.

For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

For More Details or Sample Copy please visit link @: https://www.grandviewresearch.com/industry-analysis/neglected-tropical-diseases-diagnosis-market

[bearni]

Global Neglected Tropical Diseases Diagnosis Market By Type (Conventional Method,Molecular/Modern Method), By Application (Clinical LabsHospitals /ClinicsHome Healthcare), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029

Industry analysis and future outlook on Neglected Tropical Diseases Diagnosis Global Market brings a systematic perspective of the market execution and assists in strategic decision making for worldwide and additionally the regional situation. Detailed sections provides in-depth arrangement, the Neglected Tropical Diseases Diagnosis contemplate that make sense of different perspectives relating to the global market. To begin with, the Neglected Tropical Diseases Diagnosis market definition, applications, arrangement, and industry esteem chain structure are incorporated into the answer, to target gathering of people on restricting Neglected Tropical Diseases Diagnosis market elements including drivers, limitations, openings, patterns, applications, topographical/local Neglected Tropical Diseases Diagnosis markets, and aggressive scene.

Global Neglected Tropical Diseases Diagnosis Industry Market was valued at USD XX Million in the year 2020. The market is further estimated to grow at a CAGR of XX% from 2020 to reach USD XX Million by the year 2029.

Get Quick Free Sample Brochure report at: https://www.globalresearchview.com/report/global-neglected-tropical-diseases-diagn/GRV52829/request-sample/

Neglected Tropical Diseases Diagnosis market rivalry by top makers/players, with Neglected Tropical Diseases Diagnosis deals volume, Value (USD/Unit), Revenue (Mn/Bn USD) and market size for every producer/player; the significant players include:

Abbott Laboratories Beckman Coulter/Danaher Bio-Rad Laboratories Inc. Life Technology Novartis Diagnostics. Ltd. Ortho-Clinical Diagnostics Premier Medical Corporation Ltd. Siemens Healthcare Wako Chemicals Inc.

Worldwide Neglected Tropical Diseases Diagnosis statistical surveying report uncovers that the Neglected Tropical Diseases Diagnosis business will develop with pivotal CAGR over the estimated forecast period of 2021 and 2029. The global Neglected Tropical Diseases Diagnosis market in forecast years 2021-2029, is expected to hit Mn/Bn$ XX USD by 2029. The Neglected Tropical Diseases Diagnosis market gives broad development openings over the both created and creating economies. Further, the Neglected Tropical Diseases Diagnosis business sectors could profit without a doubt from the expanding interest to bring down Neglected Tropical Diseases Diagnosis expenses of treatment over the globe.

Inquiry for Buying report to get customization at: https://www.globalresearchview.com/report/global-neglected-tropical-diseases-diagn/GRV52829/inquiry

Key Highlights of the Report:

Neglected Tropical Diseases Diagnosis Market Report provides forecast and industry outlook for the period of 2021-2029 with 2020 as the base year and covering historic data for years 2015-2019.

Neglected Tropical Diseases Diagnosis Market outlook with Porter’s 5 Forces Analysis will provide market dynamics (Drivers, Restraints, Opportunities & Threats).

Neglected Tropical Diseases Diagnosis Competitive landscape section gives you the competitive edge over other key players in the market (Key Business Strategies, Recent Development M&A, Company Overview, Products/Services Portfolio & Financial Overview).

Neglected Tropical Diseases Diagnosis Technological Scenarios & Expected Developments.

Neglected Tropical Diseases Diagnosis End-Use Industry & Consumer Behaviour Trends.

Neglected Tropical Diseases Diagnosis Export-Import Scenario.

Neglected Tropical Diseases Diagnosis Regulatory Policies across each region.

Neglected Tropical Diseases Diagnosis In-depth analysis on Industry Trends & Dynamics across each segment covered in the report.

Based on Type, Neglected Tropical Diseases Diagnosis market report shows development rate of each type, covers:

Conventional Method Molecular/Modern Method

End clients/applications, Neglected Tropical Diseases Diagnosis market report centers around the status and viewpoint for best applications/end clients, development rate for every application, this can be isolated into:

Clinical Labs Hospitals /Clinics Home Healthcare

Access More Information at: https://www.globalresearchview.com/report/global-neglected-tropical-diseases-diagn/GRV52829

In conclusion, the global Neglected Tropical Diseases Diagnosis industry report unveils research finding, outcomes, conclusions. Likewise, disclose various Neglected Tropical Diseases Diagnosis data sources, traders/vendors, suppliers, manufacturers, sales channel, and addendum. In short, the overall Neglected Tropical Diseases Diagnosis report is a lucrative document for people implicated in Neglected Tropical Diseases Diagnosis market.

Global Impact of COVID-19 Analysis:

COVID19 is an unrivaled global public health emergency that affects almost every industry, so the projected long-term impact will affect industry growth over the forecast period. The report provides insights into COVID19, taking into account changes in consumer behavior and demand, purchasing behavior, supply chain diversion, the dynamics of current market forces, and significant government intervention. Insights, analysis, estimates and forecasts considering the impact of COVID19 on the market.

About Us:

GlobalResearchView (GRV) is one of the leading market research company which aims to serve the most excellent research to the various sectors of business. We are prominent in satisfying all kinds of market research needs.

Contact US:

Jennifer Da (Head Global Business Development) – Global Research View(GRV) 701, Milton Avenue, East Ham,London. United kingdom. Pincode - 4E6 1BN Email: Jennifer@globalresearchview.com Websites:  www.globalresearchview.com Tel: +44 020 8638 7098

[priya1sharma]

Neglected Tropical Diseases Diagnosis Market

Neglected Tropical Diseases Diagnosis Market

September 24, 2021: The global Neglected Tropical Diseases Diagnosis market is expected to reach $7.6 Billion by 2025. The market is driven by factors such as huge attention paid to by healthcare organizations; which, in turn, acts as a booster for funding R&D and treatment. Healthcare facilities, immediate medical attention, and highly skilled medical professionals are expected to contribute to…

[marketfuturereports]

Neglected Tropical Diseases Diagnosis Market Dynamics, Growth Prospect and Consumption Analysis till 2025

22nd Sept 2020 - The global Neglected Tropical Diseases Diagnosis Market is expected to reach $7.6 Billion by 2025. The market is driven by factors such as huge attention paid to by healthcare organizations; which, in turn, acts as a booster for funding R&D and treatment. Healthcare facilities, immediate medical attention, and highly skilled medical professionals are expected to contribute to the global market growth. The Neglected Tropical Diseases Diagnosis market is expected to grow at a CAGR of 4.1% in the forthcoming period.

The market witnesses several opportunities in form of rise in number of NGOs, increasing R&D activities, and availability of large patient pool. However, restraints such as low medical attention, non-availability of medicines and resources, and dearth of medical professionals in extreme regions are likely to create hindrance in the Neglected Tropical Diseases Diagnosis market upto 2025.

Access Neglected Tropical Diseases Diagnosis Market Report with TOC @ https://www.millioninsights.com/industry-reports/neglected-tropical-diseases-diagnosis-market

Worms, bacteria, viruses cause neglected Tropical Diseases (NTDs) and parasites and are known to affect one-third of world population ultimately leading to poor health, poverty, and permanent disability. One of the significant ways followed by manufacturers dealing with such diseases is to define essential features of the disease to create a subsequent antidote.  Some of the common examples of NTDs are malaria, dengue, chijungunya, yaws, and African Trypanosomiasis.  The market is quadfurcated into disease, diagnostic method, service type, and geography.

The key players in the Neglected Tropical Diseases Diagnosis Industry include Thermo Fisher Scientific Inc, ZeptoMetrix Inc, InBios International Inc, Genome Diagnostics Pvt Ltd, Coris Bioconcept SPRL, Omega Diagnostics Group PLC, DiaSys Diagnostic Systems GmbH and Oscar Medicare Pvt Ltd. The market players are following strategic initiatives such as mergers and acquisitions, new product development and collaborations for development.

Neglected Tropical Diseases Diagnosis Regional Outlook (Revenue, USD Million, 2014 - 2025)

Asia Pacific

India

China

Indonesia

Malaysia

Latin America

Brazil

Venezuela

Colombia

Middle East & Africa

Nigeria

North America

U.S.

Canada

Europe

Germany

U.K.

Request a Sample Copy of Neglected Tropical Diseases Diagnosis Market Report @ https://www.millioninsights.com/industry-reports/neglected-tropical-diseases-diagnosis-market/request-sample

Table of content

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Market Variables, Trends & Scope

Chapter 4 Neglected Tropical Disease Diagnosis: Disease Estimates & Trend Analysis

Chapter 5 Neglected Tropical Disease Diagnosis: Diagnostic Methods Estimates & Trend Analysis

Chapter 6 Neglected Tropical Disease Diagnosis: End-use Estimates & Trend Analysis

Chapter 7 Neglected Tropical Disease Diagnosis: Service Type Estimates & Trend Analysis

Chapter 8 Neglected Tropical Disease Diagnosis: Regional Estimates & Trend Analysis, by Disease, Diagnostic methods, End Use, and Service type

Chapter 9 Competitive Landscape

[globalrketresearchanalysis]

Boosting Demand Of Neglected Tropical Disease Diagnosis Market Due To Emerging Trend Of Point-Of-Care Testing (POCT) Services Till 2025

The global neglected tropical diseases diagnosis market size is expected to reach USD 7.6 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 4.1% CAGR during the forecast period. The combined effect of high impact factors such as soaring disease burden, growing demand for early disease identification, and complementary advancements in technology is expected to drive growth in demand.

Rising concern regarding Neglected Tropical Diseases (NTD) and its global impact on population as well as governments has fueled demand for development of early disease detection methods. This growth in concern is evident by launch of a substantial number of programs aiming to combat NTDs.

For instance, the Global Network for Neglected Tropical Diseases aims to raise awareness and funding, both of which are essential to control and eliminate the most common NTDs. In addition, various companies are undertaking efforts to develop less complicated and inexpensive diagnostic assays for tropical diseases. This, in turn, is anticipated to support the growth of this market throughout the forecast period.

Browse full research report on Neglected Tropical Disease Diagnosis Market: www.grandviewresearch.com/industry-analysis/neglected-tropical-diseases-diagnosis-market

Further key findings from the report suggest:

By disease type, dengue captured the largest share over other NTDs in 2016. Growing dengue cases and development of novel products for its diagnosis is expected to help this segment maintain its dominance in the coming years

Conventional diagnostic methods accounted for the majority share owing to high market penetration of these techniques, including pathogen culturing, biochemical methods, gram staining, and serology tests

Molecular/modern diagnostic methods are growing at a lucrative pace and are expected to supplant conventional techniques in the coming years. This is majorly due to the advantages of molecular tests with respect to accuracy, specificity, and timelines

Centralized services held the largest share in 2016 owing to easy access to these services; however, point-of-care testing (POCT) services are anticipated exhibit lucrative growth in the coming years owing to benefits such as portability and ease of use

By end use, home healthcare is expected to be the fastest growing segment as a result of growing popularity and demand for POCT services

Asia Pacific is estimated to be the largest regional market and is expected to maintain its position throughout the forecast period thanks to constant growth in GDP, presence of a large target population, and high prevalence of neglected tropical diseases in the region

Abbott; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; and Omega Diagnostics Group PLC are some of the key players operating in this market.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global neglected tropical diseases diagnosis market on the basis of disease, diagnostic method, end use, service type, and region:

Neglected Tropical Diseases Diagnosis Disease Outlook (Revenue, USD Million, 2014–2025)

Dengue

Chikungunya

Rabies

Leprosy

Buruli Ulcer

Yaws

Lymphatic Filariasis

Taeniasis/Cysticercosis

Foodborne Trematodiases

Echinococcosis

Chagas Disease (American Trypanosomiasis)

Dracunculiasis

African Trypanosomiasis

Soil-transmitted Helminth Infections

Onchocerciasis

Schistosomiasis

Scabies and Other Ectoparasites

Snakebite Envenoming

Leishmaniasis

Neglected Tropical Diseases Diagnosis Diagnostic Method Outlook (Revenue, USD Million, 2014–2025)

Conventional Method

Molecular/Modern Method

Neglected Tropical Diseases Diagnosis Service Type Outlook (Revenue, USD Million, 2014–2025)

Centralized Service

POC Service

Neglected Tropical Diseases Diagnosis End-use Outlook (Revenue, USD Million, 2014–2025)

Clinical Labs

Hospitals /Clinics

Home Healthcare

Neglected Tropical Diseases Diagnosis Regional Outlook (Revenue, USD Million, 2014–2025)

Asia Pacific

India

China

Indonesia

Malaysia

Latin America

Brazil

Venezuela

Colombia

Middle East & Africa

Nigeria

North America

U.S.

Canada

Europe

Germany

U.K.

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-neglected-tropical-diseases-diagnosis-market

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

[chitrakullkarni]

Neglected Tropical Diseases Diagnosis Market Worldwide Opportunities, Regional Estimates and Trend Analysis, 2025

The global Neglected Tropical Diseases Diagnosis Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

The global Neglected Tropical Diseases Diagnosis market is expected to reach $7.6 Billion by 2025 with CAGR of 4.1% in the forthcoming period. The market is driven by factors such as huge attention paid to by healthcare organizations; which, in turn, acts as a booster for funding R&D and treatment. Healthcare facilities, immediate medical attention, and highly skilled medical professionals are expected to contribute to the global market growth.

Key Players:

Hoffmann-La Roche Ltd

Abbott

Thermo Fisher Scientific, Inc.

ZeptoMetrix

InBios International, Inc.

Genome Diagnostics Pvt. Ltd.

Omega Diagnostics Group PLC

Coris Bioconcept SPRL

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/neglected-tropical-diseases-diagnosis-market/request-sample

Growth Drivers:

The market witnesses several opportunities in form of rise in number of NGOs, increasing R&D activities, and availability of large patient pool. However, restraints such as low medical attention, non-availability of medicines and resources, and dearth of medical professionals in extreme regions are likely to create hindrance in the Neglected Tropical Diseases Diagnosis market upto 2025.

Diagnostic Method Outlook:

Conventional Method

Molecular/Modern Method

Service Type Outlook:

Centralized Service

POC Service

End-use Outlook:

Clinical Labs

Hospitals /Clinics

Home Healthcare

Regional Outlook:

South American market is expected to grow at a rapid pace in the forthcoming period due to reasons such as favorable opportunities and increasing awareness among the population. Rise in R&D activities and ways to deal with NTDs is likely to create favorable market conditions in the APAC sector. Tropical regions such as Africa account for a higher growth in the forecast period due to growing tribal population, moderate healthcare infrastructure, and uncontrolled birth rates. Other reasons such as lack of social hygiene, delay of medical attention, animal bite, and extreme climate is likely to contribute to the African Neglected Tropical Diseases Diagnosis market. However, medical NGOs and activists are trying ways to tackle medical problems in Africa; subsequently boosting the health awareness against NTDs among the population.

North American Neglected Tropical Disease Diagnosis market is likely to gain a moderate CAGR in the forecast period due to advanced medical infrastructure, improved health conditions, and favorable reimbursement. APAC sector is likely to gain a highly moderate CAGR owing to imbalanced health conditions caused by underlying healthcare facilities in various regions. India, Vietnam, South Korea, and China are likely to gain a popular share owing to rise in number of medical NGOs to solve NTD issues, also rise in healthcare infrastructure and medical attention are some factors that nourish the Neglected Tropical Diseases Diagnosis Industry growth.

Browse Related Category Research Reports @ https://blog.naver.com/tomclark

[rajputdishank20-blog]

Neglected Tropical Diseases Diagnosis Market Analysis, Growth Opportunities, Trends, Forecast and Outlook 2026

Formal recognition of Neglected Tropical Diseases (NTDs) in the sustainable development goals as a global target is expected to drive neglected tropical diseases diagnosis market growth. In the past, NTDs did not receive the level of attention and resources that diseases such as HIV and malaria received. However, they are now gaining significant attention from healthcare organizations, which is anticipated to increase funding for R&D of diagnostic methods and treatment options. 

Increase in programs to tackle NTDs is expected to directly impact the growth of this market. There is a growing demand for highly sensitive and rapid diagnostic tests to fulfill unmet needs. Diagnostics are vital for treatment planning, but there is still a gap between clinical diagnosis and treatment of NTDs. This hints at the growing need for relevant diagnostic tests.

Read More: https://www.marketwatch.com/press-release/neglected-tropical-diseases-diagnosis-market-analysis-growth-opportunities-trends-forecast-and-outlook-2026-2019-12-20

[myoliver123stuff]

Neglected Tropical Disease Treatments Market– Insights on Emerging Scope 2021

The global market for neglected tropical diseases should reach $2.6 billion by 2021 from $1.4 billion in 2016 at a compound annual growth rate (CAGR) of 14.1%, from 2016 to 2021.

Report Scope:

The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of nonbranded generics.

Get More Information sample: https://www.trendsmarketresearch.com/report/sample/11821

Products used for diagnosis as well as PCR techniques, kits and testing facilities are also excluded from the report.

BCC Research has categorized the markets based on regions defined by the WHO since it is the primary organization mapping disease prevalence, assisting with access to medicine and enabling partnerships. Regions include Africa, Americas, South-East Asia, Europe, Eastern Mediterranean and Western Pacific. These cover all the WHO participating countries which are described in detail in the subsequent section.

Report Includes:

– An overview of the global markets for tropical disease treatments. – Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021. – A look at the total addressable market, an indication of the number of people affected, and the current shares of key marketed therapies. – Representations of market shares by geography, company, and future outlook. – Insight on some of the newer drug candidates, clinical trials, and their end points. – Analyses of factors such as increases in resistance of vectors to common insecticides, increases in rapid diagnostic techniques, and no established treatment for newer conditions like Zika. – Profiles of major players in the industry.

Report Summary

Neglected tropical diseases are a significant cause of death and morbidity among affected communities around the world. In 2015, the total addressable market for the diseases discussed in this report was $1.4 billion and is expected to grow at a compound annual growth rate (CAGR) of 14.1% to over $2.6 billion by 2021. The global market for malaria treatments in 2015 was about $440.3 million (including preventive medicine for pregnant women and children under five years of age in Africa) and is expected to reach $757.9 million by 2021. In 2015, the global market for leishmaniasis treatments was $33.8 million although, as the disease has a focal distribution, this total does not reflect the extent of visceral leishmaniasis in affected communities.

Request for Discount : https://www.trendsmarketresearch.com/report/discount/11821

The 2015 market value for schistosomiasis was $52.5 million, out of which preventive chemotherapy was about $18 million. Coverage of preventive chemotherapy by the WHO authorities, according to our estimates is expected to grow to $46 million by 2021 for a market that, according to the demand will by then be valued at $55.8 million. Our projection of the market for Lymphatic Filariasis, for the year 2021, comes to $8,500. This falls in line with WHO’s roadmap in which the global market for preventive chemotherapy will be reduced to near negligible with a very limited market for drugs. A challenge in estimating the market size of such diseases is underreporting due to the large number of cases that go undetected or misdiagnosed.

Vaccines are making an entry into the market with recently approved GlaxoSmithKline’s Mosquirix for malaria and Sanofi’s Dengvaxia for dengue. Both near-term and long-term launches are also expected for other indications such as Zika and leishmaniasis. The projected 2017 market size for malaria vaccines is about $170 million. In 2015, the total addressable (demand) markets for dengue and Zika vaccines was $246.2 and $36.3 million but are expected to increase to about $1.3 billion and $132 million, respectively, by 2021. This surge is based on the understanding that the vaccines will be part of a routine immunization program in key markets. Innovation and launches in vaccines will continue to drive the market.

Other incentives like the U.S. FDA’s Priority Review Voucher scheme as well as public-private partnerships via platforms like DNDi and funding from organizations and governments are expected to boost research. Advances are much needed since most of the existing treatments for many tropical diseases are decades old, often unaffordable and difficult to administer. Another trend that will be driving research is the increase in parasite resistance.

Key organizations that will influence the market and have been profiled in this report include: GlaxoSmithKline, Drugs for Neglected Diseases Initiative, Medicines for Malaria Venture, Merck, Sabin Vaccine Institute, Anacor Pharmaceuticals (now Pfizer), Sanofi-Aventis and Sanofi Pasteur, Takeda, Eisai, PATH Malaria Vaccine Initiative, Novartis, Instituto Butantan, Johnson & Johnson, Bayer and Gilead Sciences.

The market has long been neglected because these diseases primarily affect marginalized communities which makes treatment expensive and diagnosis difficult. However, the recent Ebola and Zika outbreaks have highlighted the threat and the unpreparedness of the authorities.

Request For Report Analysis: https://www.trendsmarketresearch.com/report/analysis/BCC/global-markets-for-neglected-tropical-disease-treatments-market

[neha24blog]

Neglected Tropical Diseases Diagnosis Market Projected To Expand At A CAGR Of 4.1% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

Neglected Tropical Diseases Diagnosis Market Projected To Expand At A CAGR Of 4.1% For The Forecast Period From 2018 To 2025 : Grand View Research Inc.

San Francisco, 20 August 2019: The Report Neglected Tropical Diseases Diagnosis Market Analysis Report By Disease (Dengue, Chikungunya), By Diagnostic Method (Conventional, Molecular/Modern), By Service Type, By End Use, And Segment Forecasts, 2018 – 2025

The global neglected tropical diseases diagnosis market size is expected to reach USD 7.6 billion by 2025, according to a new report by Grand…